AST 7 - Pediatric Psychiatry

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/79

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:09 AM on 4/6/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

80 Terms

1
New cards

Average age of ADHD diagnosis

7 years

2
New cards

Anatomical changes

Dec brain volume

Dec DA activity in midbrain

Dec bloodflow in frontal lobe

Smaller brain structures

3
New cards

NT Deficits in ADHD

DA (unable to maintain attention, resist distractions)

NE (failure to maintain control/mood)

4
New cards

Diagnostic Criteria

at least 6 inattention or hyperactivity or impulsivity symptoms AND last >6 months AND are inappropriate for the developmental level

5
New cards

Symptoms must be present in which settings

2+ (home, school, work)

6
New cards

First line for 4-5 year olds

Behavior therapy

7
New cards

Second line for 4-5 year olds

Methylphenidate

8
New cards

First line for >6 year olds

Amphetamine or Methylphenidate

9
New cards

Second line for >6 year olds

Atomoxetine

Guanfacine XR

Clonidine XR

10
New cards

Non pharm interventions

CBT

School related intervention (BCM - behavioral classroom management)

Child related intervention (BPI)

11
New cards

Stimulant drug classes

MPH

AMP

12
New cards

Methylphenidate MOA

Inhibit presynaptic reuptake of DA and NE

13
New cards

Amphetamine MOA

Stimulate release of DA and NE into presynaptic nerve terminal

14
New cards

BBW for ALL Stimulants

High potential for abuse and dependence (SUD and Addiction)

therefore all stimulants are CII**

15
New cards

CIs for Stimulants (not necessarily hard-stops)

MAOi use in last 14 d

Symptomatic CVD

Glaucoma

Hyperthyroidism

Hx SUD

Mod-Severe HTN

16
New cards

Stimulant warnings

Elevated NE and DA levels can inc HTN

Exacerbation of psychosis

Loss of appetite

Risk of Serotonin syndrome

Lower seizure threshold

17
New cards

Ritalin duration of action

3-5h

18
New cards

Ritalin SR or Methylin ER duration of action

6-8h

19
New cards

Ritalin LA or Aptensio XR duration of action

8-12h

20
New cards

Pros of Methylphenidate (3)

Less likely to suppress appetite

Less likely to induce insomnia

Many capsules can be opened and sprinkled in food

21
New cards

Cons of Methylphenidate

Short duration with IR/SR formulations

22
New cards

Avoid Concerta if patient has

GI obstruction

Conditions that decrease motility

23
New cards

Daytrana route, administration instructions, max wear

PATCH

rotate sites, apply to hip area 2h BEFORE desired effect w/ maximum wear of 9h

24
New cards

How long will Daytrana last after removal

2-3h after

25
New cards

Daytrana counseling

Do NOT cut patch

Do not flush in toilet (fold over on itself)

26
New cards

Concerta OROS route

Osmotic release oral system

tablet acts as an osmotic pump, releasing drug over course of a day (not all at once)

27
New cards

Concerta counseling

Do NOT crush tablets

May see ghost tablet in stool

28
New cards

Dexmethylphenidate (Focalin) Counseling

Can be sprinkled on applesauce

29
New cards

Pros of Amphetamine

More predictable PK w/ long acting formulations

Can be opened and sprinkled on applesauce

30
New cards

Cons of Amphetamine

Greater growth suppression

Greater abuse potential

31
New cards

Lisdexamfetamine (Vyvanse) Pro

Lower potential for abuse (given as prodrug)

32
New cards

Lisdexamphetamine (Vyvanse) Administration counseling

You can open and dissolve in water or yogurt

33
New cards

Xelstrym Dextroamphetamine patch Counseling

SAME as Daytrana

EXCEPT can apply to hip, upper arm, chest, upper back, flank area

If falls off, can replace as long as time was <9h

34
New cards

Main Stimulant ADEs

GI

Insomnia '

HTN

Tics

Psychiatric exacerbations

35
New cards

T or F: Most stimulants require a taper off

FALSE - most don't need taper unless abuse involved

36
New cards

Non-stimulant class options for ADHD

NRIs

Central Alpha 2 agonists

37
New cards

Central Alpha 2 agonists

Clonidine

Guanfacine

38
New cards

NRIs

Atomoxetine

Viloxazine

39
New cards

BBW for ADHD NRIs

Risk of suicidal ideation

Med guide required upon dispensing

40
New cards

Atomoxetine extra CIs

Glaucoma

Pheochromocytoma (adrenal tumor)

Severe CVD

41
New cards

Atomoxetine warnings

Liver toxicity

Aggression

42
New cards

Atomoxetine metabolism

2D6 substrate

43
New cards

MOA of Alpha 2 agonists

inhibit pre-synaptic NE release --> inc blood flow to PFC

44
New cards

Alpha 2 agonists Warnings

Dose-dependet CV effects

Sedation, Drowsiness

REQUIRE A TAPER

45
New cards

Why do Alpha 2 agonists require a taper

Risk for rebound HTN

46
New cards

Alpha 2 agonists (Clonidine, Guanfacine) counseling

May take weeks to notice benefit

47
New cards

Kapvay (Clonidine) and Guanfacine counseling

Cannot be crushed

48
New cards

T or F: If a patient requires IR and ER regimen, utilize the SAME drug ingredient

TRUE

49
New cards

First line med class for ADHD

Stimulants

50
New cards

When to consider non-stimulants

Hx SUD

CIs

Non-tolerance of ADEs

51
New cards

NRI ADEs

Dec appetite

Tachycardia

52
New cards

Viloxazine Metabolism

1A2 Inhibitor

53
New cards

CBT duration recommendation

8-16 weekly sessions

54
New cards

SSRI Options

Fluoxetine

Escitalopram

55
New cards

First Line for Childhood depression >8 years

Fluoxetine

56
New cards

Escitalopram is approved for which age range for Childhood depression

>12 years

57
New cards

Symptoms of Bipolar Disorder less likely in peds

Grandiosity

Reckless behaviors

58
New cards

Bipolar disorder Meds approved

Antipsychotics - Quetiapine and Olanzepine

59
New cards

Olanzepine approved for what ages

>4 years

60
New cards

T or F: Mood stabilizers like Lithium can be used in children for Bipolar Disorder

FALSE - not effective in this population

61
New cards

First Line for Anxiety disorders in Peds

CBT

62
New cards

If anxiety symptoms are moderate-severe, which meds are considered

SSRIs: Fluoxetine, Escitalopram

SNRIs: Duloxetine

BB for social anxiety

63
New cards

Which med is helpful in pediatric social anxiety

BB (ex. propanolol)

64
New cards

Schizophrenia Sx more common in peds

Hyperactivity

Cognitive problems

Hallucinations

65
New cards

Schizophrenia First Line Tx Options

Olanzepine (>13)

Risperidone

Quetiapine

Aripiprazole

Lurasidone

66
New cards

Clozapine role in therapy for Pediatric Schizophrenia

Reserved for treatment resistant schizophrenia

For ages >6

67
New cards

Environmental factors that inc risk of Autism

Advanced paternal age

Maternal DM during pregnancy

Low birth weight

Prematurity

68
New cards

Level 1 defined as

requiring support

69
New cards

Level 2 defined as

requiring substantial support

70
New cards

Level 3 defined as

requiring very substantial support

71
New cards

Screening Red Flag Sx at 12, 14, 18 months

12 mon - does not respond to name

14 mon - does not point at objects to show interest

18 mon - does not play pretend

72
New cards

First line for Hyperactivity/Inattention symptoms of ASD

Psychostimulants

73
New cards

Alternatives for treating Hyperactivity/Inattention symptoms when First line not effective

NRIs (Atomoxetine)

Alpha 2 agonists (Clonidine, Guanfacine)

74
New cards

Atypical Antipsychotics have less data but can be used primarily to address which symptom

Aggression

75
New cards

Medication classes to treat Irritability and severe disruptive behavior

Atypical Antipsychotics - Aripiprazole, Risperidone, (FDA Approved) Consider Olanzepine, Quetiapine

Anticonvulsants

SNRI (Venlafaxine)

76
New cards

Atypical antipsychotic ADEs

Weight gain

Dyslipidemia

EPS Sx

Hyperprolactinemia

77
New cards

Medication classes to treat Repetitive behavior and Compulsions

Atypical Antipsychotics

Anticonvulsants

SSRI (Fluoxetine, Fluvoxamine)

78
New cards

Medication classes to treat Anxiety and Depression

SSRI

Alpha-2 Agonists

Atypical Antipsychotics

79
New cards

First line treatment for Anxiety and Depression symptoms

CBT

80
New cards

Adverse effect of SSRIs in children

Hyperactivation